Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types

Mutations in the chromatin remodeling gene ARID1A have recently been identified in the majority of ovarian clear cell carcinomas (OCCCs). To determine the prevalence of mutations in other tumor types, we evaluated 759 malignant neoplasms including those of the pancreas, breast, colon, stomach, lung,...

Full description

Saved in:
Bibliographic Details
Published inHuman mutation Vol. 33; no. 1; pp. 100 - 103
Main Authors Jones, Siân, Li, Meng, Parsons, D. Williams, Zhang, Xiaosong, Wesseling, Jelle, Kristel, Petra, Schmidt, Marjanka K., Markowitz, Sanford, Yan, Hai, Bigner, Darell, Hruban, Ralph H., Eshleman, James R., Iacobuzio-Donahue, Christine A., Goggins, Michael, Maitra, Anirban, Malek, Sami N., Powell, Steve, Vogelstein, Bert, Kinzler, Kenneth W., Velculescu, Victor E., Papadopoulos, Nickolas
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.01.2012
Hindawi Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mutations in the chromatin remodeling gene ARID1A have recently been identified in the majority of ovarian clear cell carcinomas (OCCCs). To determine the prevalence of mutations in other tumor types, we evaluated 759 malignant neoplasms including those of the pancreas, breast, colon, stomach, lung, prostate, brain, and blood (leukemias). We identified truncating mutations in 6% of the neoplasms studied; nontruncating somatic mutations were identified in an additional 0.4% of neoplasms. Mutations were most commonly found in gastrointestinal samples with 12 of 119 (10%) colorectal and 10 of 100 (10%) gastric neoplasms, respectively, harboring changes. More than half of the mutated colorectal and gastric cancers displayed microsatellite instability (MSI) and the mutations in these tumors were out‐of‐frame insertions or deletions at mononucleotide repeats. Mutations were also identified in 2–8% of tumors of the pancreas, breast, brain (medulloblastomas), prostate, and lung, and none of these tumors displayed MSI. These findings suggest that the aberrant chromatin remodeling consequent to ARID1A inactivation contributes to a variety of different types of neoplasms. Hum Mutat 33:100–103, 2012. © 2011 Wiley Periodicals, Inc.
Bibliography:istex:2FBE387D3250E84214B8640A2A3827D82C81F642
The Stringer Foundation; The Family and Friends of Dick Knox and Cliff Minor NIH grants (CA121113, CA62924, CA57345, CA129080, CA134292, CA130938)
SPORE (CA062924)
ark:/67375/WNG-CRVXSBX2-C
Communicated by Ian N.M. Day
The Virginia and D. K. Ludwig Fund for Cancer Research
ArticleID:HUMU21633
The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Additional Supporting Information may be found in the online version of this article.
Contract grant sponsor: The Virginia and D. K. Ludwig Fund for Cancer Research; The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; The Stringer Foundation; The Family and Friends of Dick Knox and Cliff Minor NIH grants (CA121113, CA62924, CA57345, CA129080, CA134292, CA130938); SPORE (CA062924).
ISSN:1059-7794
1098-1004
DOI:10.1002/humu.21633